ArticleCureus2025
Comparative Study of the Safety and Efficacy of a Prophylactic Insertion of Dr. Burke's Every Second Matters-Uterine Balloon Tamponade (ESM-UBT) With IM Oxytocin vs. Only IM Oxytocin for the Prevention of Atonic PPH: A Randomized Parallel Group Trial.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Uterine balloon tamponade (UBT) has emerged as a minimally invasive and cost-effective technique for managing atonic postpartum hemorrhage (PPH). This study assesses the safety and efficacy of prophylactic Dr. Burke's Every Second Matters-UBT (ESM-UBT) combined with intramuscular (IM) oxytocin compared to IM oxytocin alone in preventing atonic PPH in high-risk women. Methods This randomized parallel-group trial was conducted over 1.5 years at Shri BM Patil Medical College, Hospital, and Research Centre, Vijayapura, Karnataka. A total of 226 women with high-risk pregnancies for atonic PPH were enrolled and randomized into two groups: Group 1 received prophylactic ESM-UBT with IM oxytocin (10 units), while Group 2 received only IM oxytocin. Blood loss was measured using the Brass V drape (Microtrack Surgicals Co., Ahmedabad, Gujarat, India) and additional gauze pad weight assessment. Hemoglobin levels were recorded pre-delivery and 48 hours postpartum. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 20.0 (IBM Corp., Armonk, NY). Results The prophylactic use of ESM-UBT significantly reduced total blood loss (Mean: 198.7 mL vs. 325.2 mL, p= 0.000001) and post-delivery hemoglobin drop (Group 1: 9.9 g/dL vs. Group 2: 9.2 g/dL, p = 0.0049). Blood loss at 5, 10, and 60 minutes postpartum was consistently lower in the ESM-UBT group (p 0.0001). The additional uterotonics and blood transfusion requirement was significantly higher in the IM oxytocin-only group (p = 0.003, p = 0.013, respectively). Conclusion Prophylactic ESM-UBT significantly reduces blood loss and the need for additional interventions in high-risk women, demonstrating its potential as a vital tool in PPH prevention, particularly in resource-limited settings. Its cost-effectiveness and ease of use make it a feasible global solution for improving maternal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.